Your browser doesn't support javascript.
loading
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL.
Blombery, Piers; Lew, Thomas E; Dengler, Michael A; Thompson, Ella R; Lin, Victor S; Chen, Xiangting; Nguyen, Tamia; Panigrahi, Ashish; Handunnetti, Sasanka M; Carney, Dennis A; Westerman, David A; Tam, Constantine S; Adams, Jerry M; Wei, Andrew H; Huang, David C S; Seymour, John F; Roberts, Andrew W; Anderson, Mary Ann.
Afiliación
  • Blombery P; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Lew TE; University of Melbourne, Melbourne, VIC, Australia.
  • Dengler MA; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Thompson ER; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Lin VS; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Chen X; University of Melbourne, Melbourne, VIC, Australia.
  • Nguyen T; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Panigrahi A; Division on Oncology, Medical University of Graz, Graz, Austria; and.
  • Handunnetti SM; University of Melbourne, Melbourne, VIC, Australia.
  • Carney DA; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Westerman DA; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Tam CS; University of Melbourne, Melbourne, VIC, Australia.
  • Adams JM; Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.
  • Wei AH; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Huang DCS; Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Seymour JF; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Roberts AW; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
  • Anderson MA; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia.
Blood ; 139(8): 1198-1207, 2022 02 24.
Article en En | MEDLINE | ID: mdl-34469514
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfonamidas / Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Primarias Secundarias / Compuestos Bicíclicos Heterocíclicos con Puentes / Neoplasias Hematológicas / Mielopoyesis / Proteína X Asociada a bcl-2 / Mutación / Trastornos Mieloproliferativos Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfonamidas / Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Primarias Secundarias / Compuestos Bicíclicos Heterocíclicos con Puentes / Neoplasias Hematológicas / Mielopoyesis / Proteína X Asociada a bcl-2 / Mutación / Trastornos Mieloproliferativos Tipo de estudio: Clinical_trials Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos